Platelet-derived growth factor levels in wounds of diabetic rats

D L Doxey1, M C Ng, R E Dill

  • 1Department of Biomedical Sciences, Baylor College of Dentistry, Dallas, Texas 75266-0677, USA.

Life Sciences
|January 1, 1995
PubMed

Insights

Diabetic wound healing is impaired due to low initial levels of Platelet-Derived Growth Factor (PDGF). This suggests reduced PDGF production, not a lack of cells, hinders healing in diabetes.

Area of Science:

  • Biomedical Science
  • Wound Healing Research
  • Diabetes Complications

Background:

  • Delayed wound healing is a significant complication in diabetes.
  • The precise cellular and molecular mechanisms are not fully understood.
  • Growth factors may play a crucial role in diabetic wound repair.

Purpose of the Study:

  • To investigate Platelet-Derived Growth Factor (PDGF) levels in diabetic wound healing.
  • To compare PDGF expression in normal versus diabetic rat wound models.
  • To explore the role of PDGF in the delayed healing observed in diabetes.

Main Methods:

  • Radioimmunoassay was used to quantify PDGF levels in wound tissue.
  • Immunohistochemical analysis identified PDGF-producing cells.
  • Streptozotocin-induced diabetes model in rats was employed.

Main Results:

  • Diabetic rats showed significantly lower PDGF levels at the wound site on day 5 post-wounding compared to normal rats.
  • Both groups exhibited an increase in PDGF-immunopositive cells, with levels normalizing by day 10.
  • Diabetic wounds showed a late elevation in PDGF on day 20, unlike normal wounds.

Conclusions:

  • An initial deficit in PDGF at the wound site may contribute to impaired diabetic wound healing.
  • Reduced PDGF levels in diabetes might stem from decreased cellular production or gene expression inhibition.
  • Further research is needed to understand PDGF regulation in diabetic wound repair.